alendronate and menatetrenone

alendronate has been researched along with menatetrenone in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ishii, J	1
Koida, M	1
Akiyama, Y; Hara, K; Kobayashi, M	1
Fukushima, Y; Hamada, M; Nakase, T; Suzuki, K; Tomita, T; Tsuji, S; Yoshikawa, H	1

Reviews

2 review(s) available for alendronate and menatetrenone

Article	Year
[Comparative analyses on osteoporosis guidelines in Japan, EU and USA]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 3 Topics: Alendronate; Calcitonin; Clinical Trials as Topic; Drug Approval; Estriol; Etidronic Acid; Europe; Humans; Isoflavones; Japan; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; United States; Vitamin K 2	2002
[Pharmacotherapy of osteoporosis]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2002, Volume: 120, Issue:6 Topics: Alendronate; Androgens; Animals; Binding Sites; Bone Remodeling; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Estrogens, Non-Steroidal; Evidence-Based Medicine; Humans; Isoflavones; Osteoblasts; Osteoclasts; Osteoporosis; Phytoestrogens; Plant Preparations; Selective Estrogen Receptor Modulators; Vitamin D; Vitamin K 2	2002

Article

Year

[Comparative analyses on osteoporosis guidelines in Japan, EU and USA].

Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 3

Topics: Alendronate; Calcitonin; Clinical Trials as Topic; Drug Approval; Estriol; Etidronic Acid; Europe; Humans; Isoflavones; Japan; Osteoporosis; Practice Guidelines as Topic; Raloxifene Hydrochloride; United States; Vitamin K 2

2002

[Pharmacotherapy of osteoporosis].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2002, Volume: 120, Issue:6

Topics: Alendronate; Androgens; Animals; Binding Sites; Bone Remodeling; Clinical Trials as Topic; Estrogen Replacement Therapy; Estrogens; Estrogens, Non-Steroidal; Evidence-Based Medicine; Humans; Isoflavones; Osteoblasts; Osteoclasts; Osteoporosis; Phytoestrogens; Plant Preparations; Selective Estrogen Receptor Modulators; Vitamin D; Vitamin K 2

2002

Other Studies

2 other study(ies) available for alendronate and menatetrenone

Article	Year
Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Bone, 2004, Volume: 35, Issue:5 Topics: Alendronate; Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Calcitriol; Calcium; Elasticity; Femur; Hydroxyproline; Magnesium; Magnesium Deficiency; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Wistar; Stress, Mechanical; Urine; Vitamin K 2	2004
Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients. Modern rheumatology, 2013, Volume: 23, Issue:3 Topics: Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Treatment Outcome; Vitamin K 2	2013

Article

Year

Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.

Bone, 2004, Volume: 35, Issue:5

Topics: Alendronate; Alkaline Phosphatase; Animals; Body Weight; Bone and Bones; Bone Density; Calcitriol; Calcium; Elasticity; Femur; Hydroxyproline; Magnesium; Magnesium Deficiency; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Wistar; Stress, Mechanical; Urine; Vitamin K 2

2004

Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK₂) in postmenopausal RA patients.

Modern rheumatology, 2013, Volume: 23, Issue:3

Topics: Aged; Alendronate; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Female; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Treatment Outcome; Vitamin K 2

2013